Noonan Syndrome is a complex genetic disorder that follows an autosomal dominant inheritance pattern. It affects both men and women equally, with most cases having physical, developmental, and cardiovascular abnormalities. It is generally caused by RAAS/MAPK signaling pathway mutations, which impact cellular growth and development. Common features include short stature, heart defects, unique facial features, and cryptorchidism in men, helping to earlier diagnose. The inheritance pattern gives affected parents the 50% chance of passing on the mutation to their children. The condition may also arise from de novo mutations. The diagnosis is primarily clinical, although molecular genetic testing can confirm it. Early diagnosis allows better management with focused care, such as regular ophthalmic exams, hearing tests, and cardiac evaluations. Supportive treatments for short stature and lymphedema improve quality of life. AI-driven analysis, such as Meta Llama 3, may further improve diagnostic accuracy and personalized treatment approaches for Noonan Syndrome. In males with cryptorchidism, orchiopexy is advised by the age of one.